Assuming multiple is required, the following results were found.

  • Association Between Serum Neurofilament Light Chain Levels and Long-term Disease Course Among Patients With Multiple Sclerosis Followed up for 12 Years

    Can serum neurofilament light chain measurements serve as a reliable biomarker of disease worsening for patients with multiple sclerosis? Findings In this cohort study of 607 patients with multiple sclerosis, serum neurofilament light chain levels...

    https://mschristian.org/index.php/component/easyblog/association-between-serum-neurofilament-light-chain-levels-and-long-term-disease-course-among-patients-with-multiple-sclerosis-followed-up-for-12-years?Itemid=341
  • Syracuse has highest rate of multiple sclerosis in US, study shows - syracuse.com

    SYRACUSE, NY – Syracuse has the nation’s highest rate of multiple sclerosis, according to a new study. An analysis of medical claims by the Blue Cross Blue Shield Association found the multiple diagnosis rate in Syracuse in 2017 was 45 per 10,000...

    https://mschristian.org/index.php/component/easyblog/syracuse-has-highest-rate-of-multiple-sclerosis-in-us-study-shows-syracuse-com?Itemid=341
  • New app offers faster and easier assessment for multiple sclerosis

    accurate way for health care providers who don't have specialized training to assess the cognitive function of people with multiple sclerosis (MS). Multiple sclerosis is a chronic neurologic illness that affects the central nervous system, resulting in...

    https://mschristian.org/index.php/component/easyblog/new-app-offers-faster-and-easier-assessment-for-multiple-sclerosis?Itemid=341
  • AAN publishes new guideline on vaccinations for people with multiple sclerosis

    Reviewed by Kate Anderton, B.Sc. (Editor)Aug 28 2019 Can a person with multiple sclerosis (MS) get regular vaccines? According to a new guideline, the answer is yes. The guideline, developed by the American Academy of Neurology (AAN), recommends that...

    https://mschristian.org/index.php/component/easyblog/aan-publishes-new-guideline-on-vaccinations-for-people-with-multiple-sclerosis?Itemid=341
  • COVID-19: Preventive Measures in Multiple Sclerosis Patients and Others on Immuno-Modulators

    in the US, risk of contraction has become especially relevant within the neuroimmunology community. As many patients with multiple sclerosis, myasthenia gravis, and other neuroimmune disorders receive disease-modifying therapies (DMTs) that act on the...

    https://mschristian.org/index.php/articles/2-uncategorised/10916-covid-19-preventive-measures-in-multiple-sclerosis-patients-and-others-on-immuno-modulators
  • Study underscores the influence of sensory processing in multiple sclerosis

    new findings about the role of sensory processing and disease characteristics in the functional status of individuals with multiple sclerosis. This is one of the first studies to look at the implications of sensory processing deficits in this...

    https://mschristian.org/index.php/articles/2-uncategorised/9351-study-underscores-the-influence-of-sensory-processing-in-multiple-sclerosis
  • Rethinking neurodegenerative disease treatment: Target multiple pathological proteins

    aimed at preventing or slowing the disease often hone in on just one of these respective proteins. However, targeting multiple proteins -- known as "proteinopathies" -- at once may be the real key, according to a recent study published in Brain by Penn...

    https://mschristian.org/index.php/articles/2-uncategorised/4250-rethinking-neurodegenerative-disease-treatment-target-multiple-pathological-proteins
  • FDA approves immune-modulating therapy for treatment of multiple sclerosis

    ozanimod, an immune-modulating therapy invented at Scripps Research, for the treatment of adults with relapsing forms of multiple sclerosis. The drug is also in advanced clinical development for adults and children with moderate-to-severe ulcerative...

    https://mschristian.org/index.php/articles/2-uncategorised/10397-fda-approves-immune-modulating-therapy-for-treatment-of-multiple-sclerosis
  • "Treating MS: A Simplified Strategy Boosts Patient and Provider Satisfaction"

    of neuroimmunology evolves at an unprecedented rate, keeping up with the latest advancements in diagnosis and treatment of multiple sclerosis (MS) proves challenging. Many neurologists—even those who spend most of their time in the MS space—are...

    https://mschristian.org/index.php/articles/2-uncategorised/9438-treating-ms-a-simplified-strategy-boosts-patient-and-provider-satisfaction
  • Guidance for the use of disease modifying therapies during the COVID-19 pandemic

    after stopping include: Gilenya and Tysabri *** Members of the MS Coalition include: Accelerated Cure Project for Multiple Sclerosis, Can Do MS, Consortium of Multiple Sclerosis Centers,International Organization of Multiple Sclerosis Nurses, MS Views...

    https://mschristian.org/index.php/component/easyblog/guidance-for-the-use-of-disease-modifying-therapies-during-the-covid-19-pandemic?Itemid=341
  • High cost of MS medicines forcing patients to take 'drastic actions' - STAT

    By ED SILVERMAN @Pharmalot JANUARY 13, 2020 Click HERE to Register for the MS Beacon Newsletter THE high cost of multiple sclerosis treatments has forced 40% of patients to take “drastic actions” and alter their use of the medicines, such as cutting...

    https://mschristian.org/index.php/component/easyblog/high-cost-of-ms-medicines-forcing-patients-to-take-drastic-actions-stat?Itemid=341
  • Inflammatory cells arise from local memory cells for advanced multiple sclerosis

    Reviewed by Emily Henderson, B.Sc.May 14 2020 In the brains of people that suffer from long-term multiple sclerosis (MS), inflammatory cells are not entering the brain via the bloodstream anymore. Instead, the cells arise from local memory cells in the...

    https://mschristian.org/index.php/articles/2-uncategorised/10822-inflammatory-cells-arise-from-local-memory-cells-for-advanced-multiple-sclerosis
  • Targeting Bruton Tyrosine Kinase for Multiple Sclerosis Treatment

    An in-depth look into the expanding landscape of multiple sclerosis treatments that target bruton tyrosine kinase. By: Jennifer S. Sun, PhD - June 30, 2020 Bruton Tyrosine Kinase (BTK), a Tec family nonreceptor tyrosine kinase1 critical for the...

    https://mschristian.org/index.php/articles/2-uncategorised/10919-targeting-bruton-tyrosine-kinase-for-multiple-sclerosis-treatment
  • Robotic exoskeleton helps woman with multiple sclerosis walk - WJXT News4JAX

    Sign up for our Newsletters Latest News Health Despite having multiple sclerosis, Kathy Miska can walk with the assistance of a robotic exoskeleton that is programmed to meet her needs. (Cleveland Clinic News Service) Kathy Miska, 56, of Strongsville,...

    https://mschristian.org/index.php/articles/2-uncategorised/9747-robotic-exoskeleton-helps-woman-with-multiple-sclerosis-walk-wjxt-news4jax
  • How new gene discoveries could guide precision medicine in multiple sclerosis

    by Arlene Weintraub | Oct 31, 2019 10:20am Variants in three "complement" genes are closely associated with vision loss in multiple sclerosis, Johns Hopkins Medicine researchers discovered. (Pixabay) The most severe form of multiple sclerosis, called...

    https://mschristian.org/index.php/articles/2-uncategorised/9199-how-new-gene-discoveries-could-guide-precision-medicine-in-multiple-sclerosis
  • Researchers identify genes linked to most severe symptoms of multiple sclerosis

    by James Ives, M.Psych. (Editor)Oct 31 2019 In a bid to determine factors linked to the most debilitating forms of multiple sclerosis (MS), Johns Hopkins Medicine researchers say they have identified three so-called "complement system" genes that appear...

    https://mschristian.org/index.php/articles/2-uncategorised/9139-researchers-identify-genes-linked-to-most-severe-symptoms-of-multiple-sclerosis
  • Boston Children's Hospital researchers seem to have pinpointed the cause of multiple sclerosis

    Targeting a rogue T cell prevents and reverses multiple sclerosis in mice This could be a very significant development in medical research. The press release about it just came out today. I’m sorry I can’t go into as much detail as I’d like because I...

    https://mschristian.org/index.php/articles/2-uncategorised/8976-boston-children-s-hospital-researchers-seem-to-have-pinpointed-the-cause-of-multiple-sclerosis
  • A Surprising Contributor to Multiple Sclerosis - Technology Networks

    Cells that scientists have largely ignored when studying multiple sclerosis are actually key contributors to MS development, new research from the School of Medicine shows. The discovery suggests new avenues for devising treatments and is a vital step...

    https://mschristian.org/index.php/articles/2-uncategorised/8858-a-surprising-contributor-to-multiple-sclerosis-technology-networks
  • Blue Cross Blue Shield Association Reports Americans with Multiple Sclerosis are Three Times More Likely to Have Behavioral Health Conditions - BioSpace

    Published: Oct 08, 2019 CHICAGO, Oct. 8, 2019 /PRNewswire/ -- Commercially insured Americans with Multiple Sclerosis (MS) are three times more likely to have behavioral health conditions, including major depression and substance use disorder, than the...

    https://mschristian.org/index.php/articles/2-uncategorised/8857-blue-cross-blue-shield-association-reports-americans-with-multiple-sclerosis-are-three-times-more-likely-to-have-behavioral-health-conditions-biospace
  • ‘It’s Not A Death Sentence’: Growing Number Of Young Women Being Diagnosed With Multiple Sclerosis - CBS Philly

    PHILADELPHIA (CBS) — A growing number of young people — especially women in their 20s and 30s — are being diagnosed with multiple sclerosis. Fortunately, there are several new treatments that allow many patients to live healthy lives. MS can be...

    https://mschristian.org/index.php/articles/2-uncategorised/8608-it-s-not-a-death-sentence-growing-number-of-young-women-being-diagnosed-with-multiple-sclerosis-cbs-philly

Results 81 - 100 of 873